Since PML bodies have a key role in the control of genomic stability by governing nuclear responses and adaptation to DNA damage or viral stress [35], enhanced nTRAIL-R2 levels in tumor cells may add to genomic instability, too. The gene discussed is PML; the disease is neoplasm.